Press Play with Madeleine Brand
MDMA therapy for PTSD treatment? FDA panel says no
The panel was concerned about the strength of the evidence, allegations of participant abuse, and ill-defined therapeutic protocols. It’s a step backwards for the psychedelic movement.
The panel was concerned about the strength of the evidence, allegations of participant abuse, and ill-defined therapeutic protocols. It’s a step backwards for the psychedelic movement.